LITE SWITCH - Trademark Details
Status: 732 - Third Extension - Granted
Serial Number
88476968
Word Mark
LITE SWITCH
Status
732 - Third Extension - Granted
Status Date
2021-11-11
Filing Date
2019-06-17
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-04-14
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
MESSICK, TABITHA LEE
Statements
Goods and Services
Pharmaceutical preparations; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for the prevention or treatment of disease in connection with immune response; pharmaceutical preparations for the treatment of infectious, deficiency, hereditary, and physiological diseases; medical diagnostic reagents and assays for testing of body fluids, blood products including blood cells, healthy tissue biopsies, tumor biopsies, and microbiome cultures; medical diagnostic assays for the diagnosis of disease and infection; medical diagnostic assays for predicting and showing response to identified therapeutics
Goods and Services
Medical and pharmaceutical research services; pharmaceutical research and development; pharmaceutical research and development related to the prevention or treatment of disease with substances that stimulate the immune response; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the field of immunotherapy; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases
Pseudo Mark
LIGHT SWITCH
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-06-27
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Aaron D. Hendelman
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2019-06-20 | NEW APPLICATION ENTERED IN TRAM |
2019-06-27 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-09-08 | ASSIGNED TO EXAMINER |
2019-09-09 | NON-FINAL ACTION WRITTEN |
2019-09-09 | NON-FINAL ACTION E-MAILED |
2019-09-09 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-03-07 | EXAMINERS AMENDMENT -WRITTEN |
2020-03-07 | EXAMINERS AMENDMENT E-MAILED |
2020-03-07 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-03-07 | EXAMINER'S AMENDMENT ENTERED |
2020-03-07 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-03-06 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-03-19 | REVIEW OF CORRESPONDENCE COMPLETE |
2020-03-25 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-04-14 | PUBLISHED FOR OPPOSITION |
2020-04-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-06-09 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-07-21 | TEAS EXTENSION RECEIVED |
2020-07-21 | EXTENSION 1 FILED |
2020-07-21 | EXTENSION 1 GRANTED |
2020-07-23 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-04-13 | TEAS EXTENSION RECEIVED |
2021-04-13 | EXTENSION 2 FILED |
2021-04-13 | EXTENSION 2 GRANTED |
2021-04-15 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-11-11 | TEAS EXTENSION RECEIVED |
2021-11-11 | EXTENSION 3 FILED |
2021-11-11 | EXTENSION 3 GRANTED |
2021-11-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |